Showing results (91-100 of 413) with videos related to
Sort By:
Pageof 42
Current Opinion in Pediatrics|June 19, 2015
Influence of the human intestinal microbiome on obesity and metabolic dysfunctionHerbert Tilg, Timon E AdolphImmunity|January 25, 2011
Erythropoietin contrastingly affects bacterial infection and experimental colitis by inhibiting nuclear factor-κB-inducible immune pathwaysManfred Nairz, Andrea Schroll, Alexander R Moschen, et al.Atherosclerosis|April 13, 2018
Circulating Wnt inhibitory factor 1 levels are associated with development of cardiovascular diseaseClaudia Ress, Mariya Paulweber, Georg Goebel, et al.Scientific Reports|November 13, 2020
Cardioprotective effects of short-term empagliflozin treatment in db/db miceBernhard Radlinger, Florian Hornsteiner, Sabrina Folie, et al.Hepatology International|September 13, 2018
Metabolic effects of reduced growth hormone action in fatty liver diseaseKerstin Rufinatscha, Claudia Ress, Sabrina Folie, et al.Liver International : Official Journal of the International Association for the Study of the Liver|March 12, 2025
Risk of Serious Bacterial and Non-Bacterial Infections in People With MASLDGiovanni Targher, Herbert Tilg, Luca ValentiExpert Opinion on Biological Therapy|August 2, 2007
Mode of function of biological anti-TNF agents in the treatment of inflammatory bowel diseasesHerbert Tilg, Alexander Moschen, Arthur KaserGut|August 18, 2016
Antibiotics as deep modulators of gut microbiota: between good and evilGianluca Ianiro, Herbert Tilg, Antonio GasbarriniCardiovascular Research|June 26, 2023
Non-alcoholic fatty liver disease: pathophysiological concepts and treatment optionsChristoph Grander, Felix Grabherr, Herbert TilgFrontiers in Endocrinology|April 13, 2026
Escherichia-Shigella expansion and metabolite dysregulation in type 3c diabetes: linking microbiome alterations to exocrine pancreatic insufficiencyErika Kvalem Soto, Valeria Wagner, Julia Engl, et al.Pageof 42